Loading...
Neuroprogressive and Dementia Network NHS Lothian | Our Services

TOP HAT

Trial of Ondansetron as a Parkinson’s Hallucinations Treatment.

TOP HAT Logo

Project Details

Start Date
November 2023

Status
Open to Recruitment

Principal Investigator
Dr Gordon Duncan

NDN Study Lead
Jessica Crossan

Main Research Site
Western General Hospital

This clinical trial looks to see if the medication ondansetron can help treat hallucinations associated with Parkinson’s disease.

What Happens In This Study?

You will either be given a medicine called ondansetron or a placebo (a dummy pill that looks like the medicine but has no active ingredients). Neither you, nor the research team, will know which group you are in.

Can I Join This Study?

To take part in this medical trial, you must meet these 6 requirements:

  1. Your Diagnosis: A doctor must have confirmed that you have Parkinson’s disease OR Dementia with Lewy Bodies.
  2. Your Age: You are over 18 years old.
  3. Your Symptoms: You must be experiencing visual hallucinations due to your Parkinson’s disease OR Dementia with Lewy Bodies. These must have been happening at least once a week for the past month.
  4. Your Current Medicine: You must have been taking the same Parkinson’s medication for at least the last 1 month without making any big changes to it.
  5. Your Time: You must do your best to attend all your study visits, and follow the rules of the study until it ends.
  6. Taking the Medicine: You must be willing and able to swallow the trial medication.

Study Length: 24 weeks (6 months)

Number of appointments: 3 visits, plus check in phone calls

More information on the trial can be on the UCL website.

MAVERICK PHOTO AGENCY NDN Principal Investigator: Dr Gordon Duncan
NDN Study Lead: Jessica Crossan

To find out more about this research study, please contact:
loth.sdcrn@nhs.scot
0131 537 3804

Parkinson's UK
UCL Logo

CONTACT INFORMATION

Neuroprogressive & Dementia Research Network Office

Old Pharmacy Building
Western General Hospital
Edinburgh
EH4 2XU

Email: loth.sdcrn@nhs.scot

Telephone: 0131 537 3804

ABOUT US

The NRS Neuroprogressive Disease and Dementia Network team in NHS Lothian conduct commercial and investigator led studies for: Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Motor Neurone Disease, dementia with Lewy bodies, Progressive Supranuclear Palsy and Multiple System Atrophy.

© NHS LOTHIAN | YOUR SERVICE.